ES2131326T3 - Derivados sesquiterpenicos. - Google Patents

Derivados sesquiterpenicos.

Info

Publication number
ES2131326T3
ES2131326T3 ES95928873T ES95928873T ES2131326T3 ES 2131326 T3 ES2131326 T3 ES 2131326T3 ES 95928873 T ES95928873 T ES 95928873T ES 95928873 T ES95928873 T ES 95928873T ES 2131326 T3 ES2131326 T3 ES 2131326T3
Authority
ES
Spain
Prior art keywords
pct
compounds
sec
date
inositol monophosphatase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95928873T
Other languages
English (en)
Inventor
Stefania Stefanelli
Federica Sponga
Khalid Islam
Maurizio Denaro
Pietro Ferrari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Application granted granted Critical
Publication of ES2131326T3 publication Critical patent/ES2131326T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

LA PRESENTE INVENCION CONCIERNE A NUEVOS COMPUESTOS OBTENIDOS POR FERMENTACION DE UN MICROORGANISMO DEL GENERO DE LA MEMNONIELLA O STACHYBOTRYS, QUE SON INHIBIDORES DE LA ENZIMA INOSITOL MONOFOSFOTASA (EC 3.1.3.25).LA PRESENTE INVENCION TAMBIEN SE REFIERE AL USO DE ESTOS NUEVOS COMPUESTOS EN EL TRATAMIENTO EN DEPRESIONES MANIACAS Y FORMULACIONES FARMACEUTICAS QUE COMPRENDEN DICHOS COMPUESTOS COMO INGREDIENTES ACTIVOS; OTRO OBJETIVO ES EL USO DE ESTOS COMPUESTOS EN METODOS ANALITICOS PARA DETECTAR INOSITOL MONOFOSFOTASA.
ES95928873T 1994-03-25 1995-03-21 Derivados sesquiterpenicos. Expired - Lifetime ES2131326T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94104783 1994-03-25

Publications (1)

Publication Number Publication Date
ES2131326T3 true ES2131326T3 (es) 1999-07-16

Family

ID=8215810

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95928873T Expired - Lifetime ES2131326T3 (es) 1994-03-25 1995-03-21 Derivados sesquiterpenicos.

Country Status (9)

Country Link
US (1) US5854036A (es)
EP (1) EP0751940B1 (es)
JP (1) JP3682977B2 (es)
AT (1) ATE179975T1 (es)
DE (1) DE69509643T2 (es)
DK (1) DK0751940T3 (es)
ES (1) ES2131326T3 (es)
GR (1) GR3030786T3 (es)
WO (1) WO1995026344A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030211545A1 (en) * 2001-01-25 2003-11-13 Vawter Marquis P. Treatment of neuropsychiatric disease with protease and neurominidase inhibitors
WO2001054729A1 (en) * 2000-01-25 2001-08-02 The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Health And Human Services Treatment of neuropsychiatric disease with protease and neuraminidase inhibitors
CN1791674A (zh) * 2003-05-16 2006-06-21 詹森药业有限公司 肌－肌醇单磷酸酶的功能表征
JP4622478B2 (ja) * 2004-11-24 2011-02-02 富士電機ホールディングス株式会社 微生物計測方法
CN109045012B (zh) * 2018-09-29 2021-07-09 中国农业科学院植物保护研究所 新骨架螺环倍半萜二聚体化合物的应用
CN109053651B (zh) * 2018-09-29 2020-06-05 中国农业科学院植物保护研究所 一种螺环倍半萜二聚体化合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2405941A1 (fr) * 1977-06-30 1979-05-11 Otsuka Pharma Co Ltd Nouveaux derives sesquiterpeniques utiles notamment comme inhibiteurs du systeme complementaire et leurs procedes de preparation
US4981980A (en) * 1989-09-14 1991-01-01 Merck & Co., Inc. Drug for treating manic depression
JPH06184133A (ja) * 1992-03-04 1994-07-05 Tokyo Tanabe Co Ltd コレステロールエステラーゼ阻害剤

Also Published As

Publication number Publication date
DE69509643D1 (en) 1999-06-17
US5854036A (en) 1998-12-29
WO1995026344A1 (en) 1995-10-05
DE69509643T2 (de) 1999-10-14
JPH09510619A (ja) 1997-10-28
EP0751940B1 (en) 1999-05-12
ATE179975T1 (de) 1999-05-15
DK0751940T3 (da) 1999-11-01
EP0751940A1 (en) 1997-01-08
JP3682977B2 (ja) 2005-08-17
GR3030786T3 (en) 1999-11-30

Similar Documents

Publication Publication Date Title
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
DE60222264D1 (en) Phenylpyrazolderivate als seh-inhibitoren
DE69232929D1 (de) Saccharinderivate als proteolytische Enzyminhibitoren
TR200401739T4 (tr) Persikuinnin, üretimi ve ilaç olarak kullanımı için bir işlem
AU7725596A (en) Antithrombotic diamines
AU7994594A (en) Plaster for the treatment of nail mycoses
AU4304196A (en) Novel sulfonamides
ATE234282T1 (de) Polymorphe verbindungen
AU699480B2 (en) 2,2-Dichloroalkane carboxylic acids, processes for their production and pharmaceutical agents containing these
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
FR2771292B1 (fr) Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
AU4651700A (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
ES2131326T3 (es) Derivados sesquiterpenicos.
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
AU6087194A (en) Hiv protease inhibitors
AU3222195A (en) Organic compounds
AU5644296A (en) Novel heterocyclic chemistry
FR2702147B1 (fr) Inhibiteur de l'activite collagenase et composition cosmetique renfermant un tel inhibiteur.
ES2143916A1 (es) Derivados de benzopiranona producidos por microorganismos, procedimientos para su obtencion y uso como inhibidores de metalobetalactamasas.
AU7274198A (en) Antithrombotic agents
BG103727A (en) Hiv protease inhibitors
WO1998009951A3 (en) Intermediates for making hiv-protease inhibitors and methods of making hiv-protease inhibitors
AU5269696A (en) Anellated beta-carbolines
MX9706609A (es) Procedimiento para la obtencion de aminas opticamente activas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 751940

Country of ref document: ES